Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Tipo de estudo
Intervalo de ano de publicação
1.
Biologia (Bratisl) ; : 1-16, 2023 Feb 28.
Artigo em Inglês | MEDLINE | ID: mdl-37363646

RESUMO

Regular intake of fucosylated oligosaccharides has been associated with several benefits for human health, particularly for new-borns. Since these biologically active molecules can be found naturally in human milk, research efforts have been focused on the alternative synthetic routes leading to their production. In particular, utilization of fucosidases to perform stereoselective transglycosylation reactions has been widely investigated. Other reasons that bring these enzymes to the spotlight are their role in viral infections and cancer proliferation. Since their involvement in the pathogenesis of these diseases have been widely described, fucosidases have become a target in newly developed therapies. Finally, activity disorders of biologically important fucosidases can lead to health problems such as fucosidosis. What is common for both mechanisms is the interaction between the enzyme and substrates in and around the active site. Therefore, this review will analyse different substrate structures that have been tested in terms of their interaction with fucosidases active sites, either in synthesis or inhibition reactions. The published results will be compared from this perspective.

2.
Appl Biochem Biotechnol ; 193(11): 3553-3569, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34312785

RESUMO

The effects of water activity (aw), pH, and temperature on transglycosylation activity of α-L-fucosidase from Thermotoga maritima in the synthesis of fucosylated oligosaccharides were evaluated using different water-organic cosolvent reaction systems. The optimum conditions of transglycosylation reaction were the pH range between 7 and 10 and temperature 90-95 °C. The addition of organic cosolvent decreased α-L-fucosidase transglycosylation activity in the following order: acetone > dimethyl sulfoxide (DMSO) > acetonitrile (0.51 > 0.42 > 0.18 mM/h). However, the presence of DMSO and acetone enhanced enzyme-catalyzed transglycosylation over hydrolysis as demonstrated by the obtained transglycosylation/hydrolysis rate (rT/H) values of 1.21 and 1.43, respectively. The lowest rT/H was calculated for acetonitrile (0.59), though all cosolvents tested improved the transglycosylation rate in comparison to a control assay (0.39). Overall, the study allowed the production of fucosylated oligosaccharides in water-organic cosolvent reaction media using α-L-fucosidase from T. maritima as biocatalyst.


Assuntos
Proteínas de Bactérias/química , Fucose/química , Oligossacarídeos/síntese química , Thermotoga maritima/enzimologia , alfa-L-Fucosidase/química , Solventes/química , Água/química
3.
Rev Argent Microbiol ; 46(1): 58-65, 2014.
Artigo em Espanhol | MEDLINE | ID: mdl-24721277

RESUMO

There is a great variety of fermented milks containing lactic acid bacteria that present health-promoting properties. Milk proteins are hydrolyzed by the proteolytic system of these microorganisms producing peptides which may also perform other functions in vivo. These peptides are encrypted within the primary structure of proteins and can be released through food processing, either by milk fermentation or enzymatic hydrolysis during gastrointestinal transit. They perform different activities, since they act in the cardiovascular, digestive, endocrine, immune and nervous systems. Bioactive peptides that have an antihypertensive, antithrombotic, antioxidant and hypocholesterolemic effect on the cardiovascular system can reduce the risk factors for chronic disease manifestation and help improve human health. Most studied bioactive peptides are those which exert an antihypertensive effect by inhibiting the angiotensin-converting enzyme (ACE). Recently, the study of these peptides has focused on the implementation of tests to prove that they have an effect on health. This paper focuses on the production of ACEinhibitory antihypertensive peptides from fermented milks, its history, production and in vivo tests on rats and humans, on which its hypotensive effect has been shown.


Assuntos
Produtos Fermentados do Leite , Hipertensão/dietoterapia , Inibidores da Enzima Conversora de Angiotensina/isolamento & purificação , Animais , Bifidobacterium/enzimologia , Bovinos , Produtos Fermentados do Leite/enzimologia , Produtos Fermentados do Leite/microbiologia , Humanos , Lactobacillus/enzimologia , Lactococcus/enzimologia , Proteínas do Leite/metabolismo , Peptídeos/farmacocinética , Peptídeos/farmacologia , Ratos , Streptococcus/enzimologia
4.
Rev. argent. microbiol ; 46(1): 58-65, mar. 2014. tab
Artigo em Espanhol | LILACS | ID: lil-708697

RESUMO

Existe una gran variedad de leches fermentadas con bacterias lácticas, con propiedades que promueven la salud. Recientemente se ha comunicado que las proteínas de los alimentos pueden, además, ejercer otras funciones in vivo, por medio de sus péptidos con actividad biológica. Estos péptidos se encuentran encriptados dentro de la estructura primaria de las proteínas y pueden ser liberados por fermentación de la leche, hidrólisis enzimática, o bien durante el tránsito gastrointestinal. Las funciones que presentan son diversas, ya que pueden actuar en diferentes sistemas del cuerpo humano: el cardiovascular, el digestivo, el endocrino, el inmune y el nervioso. Los péptidos bioactivos que presentan un efecto en el sistema cardiovascular (antihipertensivo, antitrombótico, antioxidante o hipocolesterolémico) pueden reducir los factores de riesgo para la manifestación de enfermedades crónicas y ayudar a mejorar la salud humana. Los péptidos bioactivos más estudiados son aquellos que ejercen un efecto antihipertensivo a través de la inhibición de la enzima convertidora de angiotensina (ACE). Este documento se enfoca en la producción de péptidos antihipertensivos inhibidores de la ACE en leches fermentadas, en su historia, y en las pruebas in vivo realizadas en ratas y en humanos, donde se ha demostrado su efecto hipotensor.


There is a great variety of fermented milks containing lactic acid bacteria that present health-promoting properties. Milk proteins are hydrolyzed by the proteolytic system of these microorganisms producing peptides which may also perform other functions in vivo. These peptides are encrypted within the primary structure of proteins and can be released through food processing, either by milk fermentation or enzymatic hydrolysis during gastrointestinal transit. They perform different activities, since they act in the cardiovascular, digestive, endocrine, immune and nervous systems. Bioactive peptides that have an antihypertensive, antithrombotic, antioxidant and hypocholesterolemic effect on the cardiovascular system can reduce the risk factors for chronic disease manifestation and help improve human health. Most studied bioactive peptides are those which exert an antihypertensive effect by inhibiting the angiotensin-converting enzyme (ACE). Recently, the study of these peptides has focused on the implementation of tests to prove that they have an effect on health. This paper focuses on the production of ACEinhibitory antihypertensive peptides from fermented milks, its history, production and in vivo tests on rats and humans, on which its hypotensive effect has been shown.


Assuntos
Animais , Bovinos , Humanos , Ratos , Produtos Fermentados do Leite , Hipertensão/dietoterapia , Inibidores da Enzima Conversora de Angiotensina/isolamento & purificação , Bifidobacterium/enzimologia , Produtos Fermentados do Leite/enzimologia , Produtos Fermentados do Leite/microbiologia , Lactobacillus/enzimologia , Lactococcus/enzimologia , Proteínas do Leite/metabolismo , Peptídeos/farmacocinética , Peptídeos/farmacologia , Streptococcus/enzimologia
5.
Rev. argent. microbiol ; 46(1): 58-65, mar. 2014. tab
Artigo em Espanhol | BINACIS | ID: bin-131909

RESUMO

Existe una gran variedad de leches fermentadas con bacterias lácticas, con propiedades que promueven la salud. Recientemente se ha comunicado que las proteínas de los alimentos pueden, además, ejercer otras funciones in vivo, por medio de sus péptidos con actividad biológica. Estos péptidos se encuentran encriptados dentro de la estructura primaria de las proteínas y pueden ser liberados por fermentación de la leche, hidrólisis enzimática, o bien durante el tránsito gastrointestinal. Las funciones que presentan son diversas, ya que pueden actuar en diferentes sistemas del cuerpo humano: el cardiovascular, el digestivo, el endocrino, el inmune y el nervioso. Los péptidos bioactivos que presentan un efecto en el sistema cardiovascular (antihipertensivo, antitrombótico, antioxidante o hipocolesterolémico) pueden reducir los factores de riesgo para la manifestación de enfermedades crónicas y ayudar a mejorar la salud humana. Los péptidos bioactivos más estudiados son aquellos que ejercen un efecto antihipertensivo a través de la inhibición de la enzima convertidora de angiotensina (ACE). Este documento se enfoca en la producción de péptidos antihipertensivos inhibidores de la ACE en leches fermentadas, en su historia, y en las pruebas in vivo realizadas en ratas y en humanos, donde se ha demostrado su efecto hipotensor.(AU)


There is a great variety of fermented milks containing lactic acid bacteria that present health-promoting properties. Milk proteins are hydrolyzed by the proteolytic system of these microorganisms producing peptides which may also perform other functions in vivo. These peptides are encrypted within the primary structure of proteins and can be released through food processing, either by milk fermentation or enzymatic hydrolysis during gastrointestinal transit. They perform different activities, since they act in the cardiovascular, digestive, endocrine, immune and nervous systems. Bioactive peptides that have an antihypertensive, antithrombotic, antioxidant and hypocholesterolemic effect on the cardiovascular system can reduce the risk factors for chronic disease manifestation and help improve human health. Most studied bioactive peptides are those which exert an antihypertensive effect by inhibiting the angiotensin-converting enzyme (ACE). Recently, the study of these peptides has focused on the implementation of tests to prove that they have an effect on health. This paper focuses on the production of ACEinhibitory antihypertensive peptides from fermented milks, its history, production and in vivo tests on rats and humans, on which its hypotensive effect has been shown.(AU)


Assuntos
Animais , Bovinos , Humanos , Ratos , Produtos Fermentados do Leite , Hipertensão/dietoterapia , Inibidores da Enzima Conversora de Angiotensina/isolamento & purificação , Bifidobacterium/enzimologia , Produtos Fermentados do Leite/enzimologia , Produtos Fermentados do Leite/microbiologia , Lactobacillus/enzimologia , Lactococcus/enzimologia , Proteínas do Leite/metabolismo , Peptídeos/farmacocinética , Peptídeos/farmacologia , Streptococcus/enzimologia
6.
Rev. Argent. Microbiol. ; 46(1): 58-65, 2014 Jan-Mar.
Artigo em Espanhol | BINACIS | ID: bin-133710

RESUMO

There is a great variety of fermented milks containing lactic acid bacteria that present health-promoting properties. Milk proteins are hydrolyzed by the proteolytic system of these microorganisms producing peptides which may also perform other functions in vivo. These peptides are encrypted within the primary structure of proteins and can be released through food processing, either by milk fermentation or enzymatic hydrolysis during gastrointestinal transit. They perform different activities, since they act in the cardiovascular, digestive, endocrine, immune and nervous systems. Bioactive peptides that have an antihypertensive, antithrombotic, antioxidant and hypocholesterolemic effect on the cardiovascular system can reduce the risk factors for chronic disease manifestation and help improve human health. Most studied bioactive peptides are those which exert an antihypertensive effect by inhibiting the angiotensin-converting enzyme (ACE). Recently, the study of these peptides has focused on the implementation of tests to prove that they have an effect on health. This paper focuses on the production of ACEinhibitory antihypertensive peptides from fermented milks, its history, production and in vivo tests on rats and humans, on which its hypotensive effect has been shown.


Assuntos
Produtos Fermentados do Leite , Hipertensão/dietoterapia , Inibidores da Enzima Conversora de Angiotensina/isolamento & purificação , Animais , Bifidobacterium/enzimologia , Bovinos , Produtos Fermentados do Leite/enzimologia , Produtos Fermentados do Leite/microbiologia , Humanos , Lactobacillus/enzimologia , Lactococcus/enzimologia , Proteínas do Leite/metabolismo , Peptídeos/farmacocinética , Peptídeos/farmacologia , Ratos , Streptococcus/enzimologia
7.
J Agric Food Chem ; 56(14): 5859-63, 2008 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-18582081

RESUMO

Native beta-lactoglobulin binds and increases the activity of Kluyveromyces lactis beta-galactosidase. Construction of a three-dimensional (3D) model of beta-lactoglobulin showed that lysine residues 15, 47, 69, and 138 are the most exposed ones, thus the ones more likely to interact with beta-galactosidase. Molecular docking estimated the interaction energies of amino acid residues with either lactose or succinic anhydride, showing that Lys(138) is the most likely to react with both. Affinity chromatography demonstrated that succinylated beta-lactoglobulin diminished its ability to bind to the enzyme. Furthermore, when activity was measured in the presence of succinylated beta-lactoglobulin, its activating effect was lost. Since succinylation specifically blocks Lys epsilon-amino groups, their loss very likely causes the disappearance of the activating effect. Results show that the activating effect of beta-lactoglobulin on beta-galactosidase activity is due to the interaction between both proteins and that this interaction is very likely to occur through the Lys epsilon-amino groups of beta-lactoglobulin.


Assuntos
Ativação Enzimática/efeitos dos fármacos , Kluyveromyces/enzimologia , Lactoglobulinas/química , Lactoglobulinas/farmacologia , Lisina/química , beta-Galactosidase/metabolismo , Sítios de Ligação , Lactoglobulinas/metabolismo , Lisina/metabolismo , Modelos Moleculares , Termodinâmica
8.
Biotechnol Bioeng ; 93(6): 1123-9, 2006 Apr 20.
Artigo em Inglês | MEDLINE | ID: mdl-16470870

RESUMO

The present study evaluated the influence of water activity and lactose concentration on the synthesis of galactooligosaccharides (GOS), by means of a hyperthermophilic beta-glycosidase in an organic system. The production of GOS gradually grew as water activity increased in the reaction system; later, their synthesis decreased as water activity increased. The authors used the response surface methodology to study how different water activities and different concentrations of lactose influenced the synthesis of GOS and their length. In every case, the variable that proved to have the greatest effect on GOS synthesis was water activity. Maximum GOS3 synthesis was reached at a water activity interval of 0.44-0.57, with lactose concentrations of 0.06%-0.1%, while GOS4 and GOS5 maxima were reached at water activity intervals of 0.47-0.57 and 0.49-0.60, respectively. The research showed that higher water activity was required to synthesize GOS of greater length. Synthesis of GOS would then depend on the flexibility of the enzyme, which in turn would depend on water activity of the reaction system. This hypothesis was supported by experiments in which the reaction temperature was modified in order to change the flexibility of the enzyme, thus leading to longer GOS.


Assuntos
Acetona/química , Galactose/biossíntese , Glicosídeo Hidrolases/metabolismo , Oligossacarídeos/biossíntese , Água/química , Catálise , Galactose/química , Glucose/química , Glucose/metabolismo , Glicosídeo Hidrolases/química , Temperatura Alta , Cinética , Lactose/química , Lactose/metabolismo , Oligossacarídeos/química , Compostos Orgânicos/química , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Solventes/química , Temperatura
9.
J Agric Food Chem ; 53(26): 10200-4, 2005 Dec 28.
Artigo em Inglês | MEDLINE | ID: mdl-16366715

RESUMO

The secondary structure of Kluyveromyces lactis beta-galactosidase was determined by circular dichroism. It is mainly a beta-type protein, having 22% beta-turns, 14% parallel beta-sheet, 25% antiparallel beta-sheet, 34% unordered structure, and only 5% alpha-helix. The structure-activity relationship as a function of the pH was also studied. The pH conditions leading to the highest secondary structure content (100% ellipticity) of the enzyme was found at pH 7.0; at pH 6.5-7.0, the percent ellipticity decreased slightly, suggesting little structural change, but the activity decreased significantly, probably because of variations in critical residues. On the other hand, at pH's above 7.0, a more noticeable change in ellipticity was observed due to structural changes; the CD analysis showed a small increase in the helical content toward higher pH, whereas the maximum activity was found at pH 7.5, meaning that the changes produced in the secondary structure at this pH favored the interaction between the enzyme and the substrate.


Assuntos
Kluyveromyces/enzimologia , beta-Galactosidase/química , Cromatografia em Gel , Dicroísmo Circular , Eletroforese em Gel de Poliacrilamida , Proteínas Fúngicas/biossíntese , Proteínas Fúngicas/química , Concentração de Íons de Hidrogênio , Lactase/química , Lactase/isolamento & purificação , Conformação Proteica , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...